A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.

Abstract:

OBJECTIVE:The aromatization of androgenic precursors is the main source of estrogens in postmenopausal women. We tested the hypothesis that allelic variants of the genes coding for aromatase and estrogen receptors (ER) could interact to determine the estrogenic signals on the bone tissue and, consequently, bone mineral density (BMD). DESIGN:Cross-sectional study including 331 postmenopausal women. METHODS:BMD was measured by dual energy x-ray absorptiometry. A CG polymorphism of the aromatase gene as well as three polymorphisms of ERalpha (a TA repeat in the promoter region, a C T single nucleotide polymorphism (SNP) in intron 1 and an AG SNP in exon 8) and a CA repeat polymorphism of ERbeta were studied. RESULTS:Age, body weight and the aromatase genotype were associated with BMD. Allelic variants of ERbeta and the exon 8 of ERalpha did not show a significant association with BMD. The polymorphisms located on the promoter and intron 1 of ERalpha interacted strongly with aromatase. Thus, in women TT homozygous for the ERalpha gene, there was a marked influence of aromatase genotypes on BMD: spine BMD was 0.724 +/- 0.027 g/cm2 in women with CC aromatase alleles and 0.926 +/- 0.032 g/cm2 in those with GG alleles (P < 0.001). Hip BMD in women with CC and GG aromatase genotypes was 0.722 +/- 0.020 and 0.842 +/- 0.026 g/cm2 respectively (P = 0.002). On the contrary, there were no aromatase-related differences in BMD in women with CT/CC alleles of ERalpha. Similarly, aromatase-related differences in BMD were found in women with short alleles at the promoter region of ERalpha, but not in those with long alleles. Both ERalpha polymorphisms were in strong linkage disequilibrium (P < 0.001). CONCLUSION:These results suggest that the interaction between polymorphisms of genes involved in estrogen synthesis and estrogen signaling exerts an important influence on BMD in postmenopausal women, thus helping to explain, in part, its heritable component. Nevertheless, further studies are warranted to confirm this gene-to-gene interaction in other populations.

journal_name

Eur J Endocrinol

authors

Riancho JA,Zarrabeitia MT,Valero C,Sañudo C,Mijares V,González-Macías J

doi

10.1530/eje.1.02189

subject

Has Abstract

pub_date

2006-07-01 00:00:00

pages

53-9

issue

1

eissn

0804-4643

issn

1479-683X

pii

155/1/53

journal_volume

155

pub_type

杂志文章
  • Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene.

    abstract:Background:Autosomal dominant neurohypophyseal diabetes insipidus (adNDI) is caused by arginine vasopressin (AVP) deficiency resulting from mutations in the AVP-NPII gene encoding the AVP preprohormone. Aim:To describe the clinical and molecular features of Italian unrelated families with central diabetes insipidus. ...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-19-0299

    authors: Patti G,Scianguetta S,Roberti D,Di Mascio A,Balsamo A,Brugnara M,Cappa M,Casale M,Cavarzere P,Cipriani S,Corbetta S,Gaudino R,Iughetti L,Martini L,Napoli F,Peri A,Salerno MC,Salerno R,Passeri E,Maghnie M,Perrotta

    更新日期:2019-09-01 00:00:00

  • A four year dose-response study of recombinant human growth hormone treatment of growth hormone deficient children: effects on growth, bone growth and bone mineralization.

    abstract::To evaluate the effects of two regimens of recombinant human GH (rhGH) on growth, bone growth and bone mineralization in GH deficient children, we studied two groups (A and B), each including 16 GH deficient children matched for sex, age, body mass index, height, height velocity and bone age/chronological age ratio (B...

    journal_title:European journal of endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1530/eje.0.1420042

    authors: Radetti G,Buzi F,Paganini C,Martelli C,Adami S

    更新日期:2000-01-01 00:00:00

  • Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature.

    abstract:OBJECTIVE:TSH-secreting pituitary tumors (TSH-omas) are a rare cause of hyperthyroidism and account for <1% of all pituitary adenomas. Failure to recognize the presence of a TSH-oma may result in dramatic consequences such as thyroid ablation that may cause further growth in pituitary tumor. The primary goal of the tre...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,评审

    doi:10.1530/EJE-07-0098

    authors: Kienitz T,Quinkler M,Strasburger CJ,Ventz M

    更新日期:2007-07-01 00:00:00

  • Distinct inflammatory gene expression in extraocular muscle and fat from patients with Graves' orbitopathy.

    abstract:OBJECTIVE:This study sought to compare patients with thyroid eye disease (TED) and normal controls with respect to the expression of the NR3C1, CHUK, IKBKB, FOS, NFKB and HSD11B1 genes in orbital fat (OF) and extraocular muscle (EOM). DESIGN AND METHODS:A prospective study design was used to evaluate 34 TED patients a...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-16-0945

    authors: Romero-Kusabara IL,Filho JV,Scalissi NM,Melo KC,Demartino G,Longui CA,Melo MR,Cury AN

    更新日期:2017-04-01 00:00:00

  • Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency.

    abstract:OBJECTIVE:GH deficiency (GHD) and glucocorticoid excess are associated with increased risk of fragility fractures. We aimed to evaluate whether the prevalence of vertebral fractures may be influenced by glucocorticoid over-replacement in hypopituitary males with GHD. DESIGN:Cross-sectional study. METHODS:Fifty-one ad...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-10-0125

    authors: Mazziotti G,Porcelli T,Bianchi A,Cimino V,Patelli I,Mejia C,Fusco A,Giampietro A,De Marinis L,Giustina A

    更新日期:2010-07-01 00:00:00

  • Effects of calcium supplementation on bone loss and fractures in congestive heart failure.

    abstract:BACKGROUND:Cross-sectional studies have shown that more than 50% of patients with congestive heart failure (CHF) have decreased bone mineral density (BMD). There is limited knowledge about the longitudinal changes of BMD and how to treat bone loss in patients with CHF. METHODS:The present study was a prospective, long...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,随机对照试验

    doi:10.1530/EJE-06-0614

    authors: Frost RJ,Sonne C,Wehr U,Stempfle HU

    更新日期:2007-03-01 00:00:00

  • Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats.

    abstract::Glucocorticoid treatment causes osteoporosis and growth retardation in humans. Insulin-like growth factor I (IGF-I) stimulates differentiation and replication of cultured osteoblast-like cells and induces longitudinal bone growth in IGF-I-deficient rats. We investigated the influence of subcutaneously infused IGF-I on...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1300387

    authors: Binz K,Schmid C,Bouillon R,Froesch ER,Jürgensen K,Hunziker EB

    更新日期:1994-04-01 00:00:00

  • Complex alternative splicing of the GH-V gene in the human testis.

    abstract::The human growth hormone variant (GH-V) gene is expressed during pregnancy in the syncytiotrophoblast and, as shown recently, in the normal human testis. In addition to the classical transcript encoding for the 22 K major form, intron D-retaining processed mRNAs (GH-V2) have also been described in both tissues. In the...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1390424

    authors: Untergasser G,Hermann M,Rumpold H,Berger P

    更新日期:1998-10-01 00:00:00

  • High serum luteinizing hormone levels induce ovarian delta4 cytochrome P450c17alpha down-regulation in hirsute women: complete effect on 17-hydroxylase and partial effect on 17,20-lyase.

    abstract::It is well known that normal and mildly elevated luteinizing hormone (LH) levels induce increased activity of ovarian 17-hydroxylase and 17,20-lyase, the cytochrome P450cl7alpha (P450) enzymes. This leads to increased ovarian 17alpha-hydroxyprogesterone (17-OHP) and androstenedione production. In contrast, it has been...

    journal_title:European journal of endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1530/eje.0.1390304

    authors: Rieu M,Mourrieras F,Riveline JP,Laplanche S,Both D,Kuhn JM

    更新日期:1998-09-01 00:00:00

  • Safety and rapid efficacy of guideline-based gender affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.

    abstract:OBJECTIVE:Hormone treatment is an important part of gender reassignment therapy in gender dysphoria. Previous data about efficacy and safety are commonly based on small cohorts or they comprise former cohorts under meanwhile obsolet therapy regimes. Our objective was to investigate these topics in a large cohort of ind...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-19-0463

    authors: Meyer G,Mayer M,Mondorf A,Fluegel AK,Herrmann E,Bojunga J

    更新日期:2019-11-01 00:00:00

  • Nitric oxide mediates abnormal responsiveness of thyroid arteries in methimazole-treated patients.

    abstract:OBJECTIVE:We studied the intervention of nitric oxide (NO), prostacyclin and endothelium-derived hyperpolarizing factor (EDHF) in mediating responses to acetylcholine in thyroid arteries from euthyroid and methimazole-treated (MT) patients. DESIGN AND METHODS:Branches of the superior thyroid artery were obtained from ...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.1.01889

    authors: Ortega J,Vila JM,Mauricio MD,Segarra G,Medina P,Martínez-León JB,Lluch S

    更新日期:2005-04-01 00:00:00

  • Inhibitory effect of alcohol on ghrelin secretion in normal man.

    abstract:BACKGROUND:Human appetite is stimulated by alcohol but the underlying mechanism is unknown. It is possible that hunger-stimulating hormones are mediators of this effect of alcohol. Ghrelin stimulates hunger, but how alcohol affects human ghrelin secretion has never been studied before. OBJECTIVE:To investigate whether...

    journal_title:European journal of endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1530/eje.1.01905

    authors: Calissendorff J,Danielsson O,Brismar K,Röjdmark S

    更新日期:2005-05-01 00:00:00

  • Associations between subcutaneous fat density and systemic inflammation differ by HIV serostatus and are independent of fat quantity.

    abstract:Objectives:Adipose tissue (AT) density measurement may provide information about AT quality among people living with HIV. We assessed AT density and evaluated relationships between AT density and immunometabolic biomarker concentrations in men with HIV. Design:Cross-sectional analysis of men enrolled in the Multicente...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,多中心研究

    doi:10.1530/EJE-19-0296

    authors: Lake JE,Debroy P,Ng D,Erlandson KM,Kingsley LA,Palella FJ,Budoff MJ,Post WS,Brown TT

    更新日期:2019-10-01 00:00:00

  • Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.

    abstract:OBJECTIVE:Somapacitan is a reversible albumin-binding growth hormone (GH) derivative, developed for once-weekly administration. This study aimed to evaluate the safety of once-weekly somapacitan vs once-daily Norditropin®. Local tolerability and treatment satisfaction were also assessed. DESIGN:26-week randomized, con...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1530/EJE-17-1073

    authors: Johannsson G,Feldt-Rasmussen U,Håkonsson IH,Biering H,Rodien P,Tahara S,Toogood A,Rasmussen MH,REAL 2 Study Group.

    更新日期:2018-05-01 00:00:00

  • The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.

    abstract:BACKGROUND:Glucocorticoids are the mainstay of immunosuppression for active moderate-severe Graves' orbitopathy (GO). AIM:To analyze the response to therapy and the contribution of glucocorticoid receptor (GR) gene polymorphisms to the therapeutic outcome of intravenous glucocorticoids (IVGC) in active moderate-severe...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-13-0611

    authors: Vannucchi G,Covelli D,Campi I,Origo D,Currò N,Cirello V,Dazzi D,Beck-Peccoz P,Salvi M

    更新日期:2013-11-22 00:00:00

  • Effects of age and gender on pituitary-adrenocortical responsiveness in humans.

    abstract::This study compared plasma concentrations of adrenocorticotropin (ACTH) and cortisol in young men (N = 10, mean age 24.4 years), young women (N = 10, mean age 25.4 years), old men (N = 8, mean age 81.6 years) and old women (N = 8, mean age 83.5 years) under basal resting conditions and after stimulation with either hu...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1320705

    authors: Born J,Ditschuneit I,Schreiber M,Dodt C,Fehm HL

    更新日期:1995-06-01 00:00:00

  • Transition in endocrinology: induction of puberty.

    abstract::Puberty is the period during which we attain adult secondary sexual characteristics and reproductive capability. Its onset depends upon reactivation of pulsative GNRH, secretion from its relative quiescence during childhood, on the background of intact potential for pituitary-gonadal function. This review is intended:...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,评审

    doi:10.1530/EJE-13-0894

    authors: Dunkel L,Quinton R

    更新日期:2014-06-01 00:00:00

  • Relationship between the release of prolactin and endothelin-1 in human decidualized endometrial cells.

    abstract::The study was undertaken to investigate the interaction between the release of endothelin-1 (ET-1) and prolactin (PRL) from human decidualized endometrial cells, and the effects of transforming growth factor (TGF)-beta 1 on the release of ET-1 and PRL from human decidual cells in the early stage of pregnancy. Stromal ...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1370200

    authors: Kubota T,Taguchi M,Kobayashi K,Masuda M,Aso T

    更新日期:1997-08-01 00:00:00

  • Effects of deflazacort and cortisone on body growth, thymus weight and gene expression of growth-related proteins in the rat.

    abstract::Deflazacort is an oxazoline derivative of cortisone with presumably less serious side effects, but its effects on growth factors are unknown. The present experiments in Long Evans rats were carried out to investigate how deflazacort administration affected the growing rat, especially in relation to hepatic insulin-lik...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1310652

    authors: Latta K,Krieg RJ Jr,Chan W,Hisano S,Chan JC

    更新日期:1994-12-01 00:00:00

  • No relationship between identified variants in the uncoupling protein 2 gene and energy expenditure.

    abstract:OBJECTIVE:The uncoupling protein 2 (UCP2) uncouples respiration from the oxidative phosphorylation in most cell types, predominantly in white fat and skeletal muscle. Since a decreased basal metabolic rate (BMR) would increase the susceptibility to weight gain, genetic alterations in the UCP2 gene could contribute to t...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1390217

    authors: Klannemark M,Orho M,Groop L

    更新日期:1998-08-01 00:00:00

  • Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase.

    abstract:OBJECTIVE AND DESIGN:Based on our clinical experience with combined gene therapy of glioblastoma, we developed a retroviral vector expressing two therapeutic genes (i.e. thymidine kinase of herpes simplex virus, HSV-TK, and interleukin-2, IL-2) and evaluated its efficiency in vitro and in vivo. METHODS:Expression of t...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1480073

    authors: Barzon L,Bonaguro R,Castagliuolo I,Chilosi M,Franchin E,Del Vecchio C,Giaretta I,Boscaro M,Palù G

    更新日期:2003-01-01 00:00:00

  • Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours.

    abstract::Pituitary tumours express both somatostatin and dopamine receptors. Medical treatment with somatostatin analogues is a cornerstone of GH- and TSH-secreting tumours, while treatment with dopamine agonists is a cornerstone of prolactin-secreting tumours. Dopamine agonists have also demonstrated some efficacy in patients...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,评审

    doi:10.1530/eje.1.02348

    authors: Colao A,Filippella M,Pivonello R,Di Somma C,Faggiano A,Lombardi G

    更新日期:2007-04-01 00:00:00

  • Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ.

    abstract:OBJECTIVE:Apelin is a novel adipokine acting on APJ receptor, regulated by insulin and tumor necrosis factor-alpha (TNF-alpha) in adipose tissue (AT). Plasma apelin levels are increased in obese hyperinsulinemic subjects. The aim was to investigate whether the hypocaloric diet associated with weight loss modifies the e...

    journal_title:European journal of endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1530/EJE-08-0039

    authors: Castan-Laurell I,Vítkova M,Daviaud D,Dray C,Kováciková M,Kovacova Z,Hejnova J,Stich V,Valet P

    更新日期:2008-06-01 00:00:00

  • TLR4 gene polymorphisms: evidence for protection against type 2 diabetes but not for diabetes-associated ischaemic heart disease.

    abstract:OBJECTIVE:Several factors either predisposing or protecting from the onset of diabetes mellitus type 2 (DM2) have been proposed. Two specific polymorphisms of toll-like receptor 4 (TLR4; Asp299Gly and Thr399Ile) have recently been identified either as candidate protector genes against DM2 and associated neuropathy or r...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-11-0280

    authors: Manolakis AC,Kapsoritakis AN,Tiaka EK,Sidiropoulos A,Gerovassili A,Satra M,Vamvakopoulou D,Tsiopoulos F,Papanas N,Skoularigis I,Potamianos SP,Vamvakopoulos N

    更新日期:2011-08-01 00:00:00

  • Familial neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin II gene.

    abstract:BACKGROUND:Familial neurohypophyseal (central) diabetes insipidus (DI) is caused by mutations in the arginine vasopressin-neurophysin II (AVP-NPII) gene. The majority of cases is inherited in an autosomal dominant way. In this study, we present the clinical features of a mother and her son with autosomal dominant neuro...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-11-0048

    authors: de Fost M,van Trotsenburg AS,van Santen HM,Endert E,van den Elzen C,Kamsteeg EJ,Swaab DF,Fliers E

    更新日期:2011-07-01 00:00:00

  • Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe.

    abstract:BACKGROUND:Conventional glucocorticoid (GC) replacement for patients with adrenal insufficiency (AI) is inadequate. Patients with AI continue to have increased mortality and morbidity and compromised quality of life despite treatment and monitoring. OBJECTIVES:i) To review current management of AI and the unmet medica...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,评审

    doi:10.1530/EJE-13-0450

    authors: Grossman A,Johannsson G,Quinkler M,Zelissen P

    更新日期:2013-10-21 00:00:00

  • Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review.

    abstract::In addition to the classical hormones, the production of numerous polypeptide growth factors, cytokines, vasogenic substances and neuropeptides by pituitary cells has been demonstrated. Expression of the corresponding receptors on pituitary cells enables these factors to influence growth and function of the pituitary ...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章,评审

    doi:10.1530/eje.0.1350515

    authors: Renner U,Pagotto U,Arzt E,Stalla GK

    更新日期:1996-11-01 00:00:00

  • Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age.

    abstract:BACKGROUND:Some cases of apparently idiopathic GH deficiency (GHD) may be caused by pituitary autoimmunity. OBJECTIVE:To study the variations in pituitary function and antipituitary antibodies (APA) from childhood to transition age in patients with apparently idiopathic GHD. DESIGN:We conducted a longitudinal study. ...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/EJE-15-0766

    authors: De Bellis A,Bellastella G,Maiorino MI,Aitella E,Lucci E,Cozzolino D,Bellastella A,Bizzarro A,Giugliano D,Esposito K,Italian Autoimmune Hypophysitis Network Group.

    更新日期:2016-03-01 00:00:00

  • Inhibition of insulin secretion via distinct signaling pathways in alpha2-adrenoceptor knockout mice.

    abstract:OBJECTIVE:Adrenaline inhibits insulin secretion through activation of alpha(2)-adrenoceptors (ARs). These receptors are linked to pertussis toxin-sensitive G proteins. Agonist binding leads to inhibition of adenylyl cyclase, inhibition of Ca(2+) channels and activation of K(+) channels. Recently, three distinct subtype...

    journal_title:European journal of endocrinology

    pub_type: 杂志文章

    doi:10.1530/eje.0.1490343

    authors: Peterhoff M,Sieg A,Brede M,Chao CM,Hein L,Ullrich S

    更新日期:2003-10-01 00:00:00

  • Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.

    abstract:OBJECTIVE:Epidemiological studies have shown an increased risk for prostate carcinoma in men with serum IGF-I in the upper part of the age-related reference range. Recombinant human GH (rhGH) is widely used in patients with GH deficiency, usually raising the serum IGF-I levels into the normal range: safety surveillance...

    journal_title:European journal of endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1530/eje.0.1470059

    authors: le Roux CW,Jenkins PJ,Chew SL,Camacho-Hübner C,Grossman AB,Besser GM,Monson JP

    更新日期:2002-07-01 00:00:00